Enterprise League logo

Product

131 I-DGT-207

BIOTECHNOLOGY

bydGenThera

United States (US)

ABOUT THE PRODUCT

A bioligand-tagged conjugate demonstrating superior biodistribution compared to other I-131 TRTs in an undisclosed human cancer xenograft model, showcasing the effectiveness of matching tag and ligand physicochemical properties.

Information is owner-confirmed

Last updated 2 months ago

Price range
N/A